Skip to main navigation Skip to search Skip to main content

Maintenance Olaparib in Patients With Newly Diagnosed Advanced Ovarian Cancer

  • Kathleen Moore
  • , Nicoletta Colombo
  • , Giovanni Scambia
  • , Byoung Gie Kim
  • , Ana Oaknin
  • , Michael Friedlander
  • , Alla Lisyanskaya
  • , Anne Floquet
  • , Alexandra Leary
  • , Gabe S. Sonke
  • , Charlie Gourley
  • , Susana Banerjee
  • , Amit Oza
  • , Antonio González-Martín
  • , Carol Aghajanian
  • , William Bradley
  • , Cara Mathews
  • , Joyce Liu
  • , Elizabeth S. Lowe
  • , Ralph Bloomfield
  • Paul Disilvestro
  • University of Oklahoma
  • University of Milan - Bicocca
  • IRCCS
  • Vall d'Hebron Institute of Oncology
  • University of New South Wales
  • St Petersburg Oncology Dispensary
  • Groupe D'Investigateurs Nationaux pour L'Etude des Cancers Ovariens
  • Centre Georges-François Leclerc
  • Gustave Roussy
  • Netherlands Cancer Institute
  • University of Edinburgh
  • Royal Marsden NHS Foundation Trust
  • Princess Margaret Cancer Centre
  • University of Texas MD Anderson Cancer Center
  • Memorial Sloan-Kettering Cancer Center
  • Medical College of Wisconsin
  • Women and Infants Hospital of Rhode Island
  • Dana-Farber Cancer Institute
  • AstraZeneca

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)86-87
Number of pages2
JournalObstetrical and Gynecological Survey
Volume74
Issue number2
DOIs
StatePublished - 1 Feb 2019

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this